Search filters

List of works by Daniel S Chen

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

scientific article published on December 2012

Abscopal effect in a patient with melanoma

scientific article published on 01 May 2012

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

scientific article published on 15 August 2013

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

scientific article published on 12 December 2016

BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.

scientific article

Cellular immunotherapy: antigen recognition is just the beginning.

scientific article

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

scientific article published on 04 June 2018

Combinations of Bevacizumab With Cancer Immunotherapy

scientific article published on 01 July 2018

De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.

scientific article published on April 2016

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

scientific article published on 01 March 2020

Detection and characterization of cellular immune responses using peptide-MHC microarrays

scientific article

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

scientific article published on 17 May 2013

Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).

scientific article

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

scientific article published on 01 April 2020

Introduction by the Guest Editors: Bevacizumab

scientific article published on 01 July 2018

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

scientific article (publication date: 27 November 2014)

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray

scientific article

Molecular biomarker analyses using circulating tumor cells

scientific article (publication date: 8 September 2010)

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

scientific article published on 19 October 2012

New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016

scientific article

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

scientific article (publication date: 27 November 2014)

Retroviral Vector-Mediated Transfer of an Antisense Cyclin G1 Construct Inhibits Osteosarcoma Tumor Growth in Nude Mice ⬇️

scientific article published on September 20, 1997

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab

scientific article published on 29 July 2019

T cells use two directionally distinct pathways for cytokine secretion.

scientific article published on 29 January 2006

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

scientific article published on 14 February 2018

Top 10 Challenges in Cancer Immunotherapy

scientific article published on 01 January 2020

VEGF in Signaling and Disease: Beyond Discovery and Development

scientific article published on 01 March 2019

Paulina is supported by:

About Paulina

Help